On September 29, 2026, a U.S. federal grand jury indicted two Indian nationals, Swapnadip Roy and Vicky Ramancha, for smuggling and selling counterfeit Ozempic from China to the United States between July 2023 and April 2024. Roy pleaded not guilty after being extradited from Italy, while Ramancha remains at large. The defendants are charged with multiple crimes including conspiracy and drug smuggling, facing up to…
U.S. says two Indian nationals indicted in counterfeit Ozempic smuggling scheme (this article)
